Why This Meeting Remains the Priority for Your Biopharma Peers
Remaining your longest-standing, global forum for the precision medicine community, the 16th World Clinical Biomarkers & Companion Diagnostics Summit continues to unite biopharma, diagnostic, regulatory, healthcare, testing labs and multimodal organizations year after year. Find out exactly why your peers are keen to join us once more.
"This forum offers great networking opportunities across diagnostics, pharma, and biosample vendors. I appreciate the opportunity to cross paths with this global network and the ample time to connect"
Director, Translational Medicine Strategy, AstraZeneca
"This conference facilitates many valuable discussions with potential partners. I like the fact that the conference keeps getting a little bit larger every year and that it continues to attract larger and larger precision medicine vendors"
Director, Diagnostics,
Bristol Myers Squibb
"Through case studies and thought leader engagement, this meeting provides an opportunity to network directly with the diagnostic manufacturers that offer potential solutions for translational studies and clinical trials"
Senior Director, Global Regulatory Affairs, Digital Health & Drug Delivery,
Eli Lilly
"As in the past, this Summit provided a wide range of topics for the different audience members covering all stages of the CDx lifecycle. The real-life examples and case studies shared by presenters were insightful and helpful in providing potential mitigation strategies, should our organizations fall into similar scenarios. Alongside this, the venue, snacks, and opportunities to network were great"
Director, Vendor Quality & Good Clinical Practice, Regeneron Pharmaceuticals
"Uniquely, the World CB & CDx meeting has all current and potential future diagnostics partners in one space to discuss collaborations. Hearing about all the new IVD innovations in the space makes this the best conference for me and my team"
Senior Director, IVD Development Lead, Sanofi
"This summit delivered high quality speakers and case studies showing the challenges associated with CDx from development through to reimbursement, that will guide me in biomarker strategies for future studies"
Volunteer, American Cancer Society
"The congress is a great opportunity to meet with our precision medicine peers in the industry and share best practices"
Director, Precision Medicine & Global Diagnostics Strategy, Amgen
"This meeting offered hyper relevant presentation topics and extensive expertise across the pharma and diagnostics space"
Head, CDx Development, Genentech
Register Your Interest for 2026
- Free* to Attend for Biopharma & Academia
- The Globally Leading Biomarker & Companion Diagnostic Forum
- Strategic Rx-Dx Co-Development & Partnership Selection Panels
- Biomarker Panels in Oncology, Hematology, Neurological, Chronic, Autoimmune, & Rare Disease
- Brand-New Case Studies on Digital Pathology, Multimodal Data and AI-Enabled Precision Medicine
- Exclusive Networking & Partnerships Opportunities
Explore the Agenda
Hear the latest translational, clinical and post-approval breakthroughs and gain exclusive insights into precision medicine innovations during our packed agenda, interactive roundtables, and new drug-diagnostic partnerships panel discussions
Partner With Us
Position yourself alongside other leading IVD and CDx solution providers to ensure your brand is at the heart of precision medicines deals and collaborations
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning a range of precision therapy modalities and indications, and make critical connections during our dedicated networking sessions